Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Tuberculosis (Edinburgh, Scotland)|August 6, 2019
A structural insight of bedaquiline for the cardiotoxicity and hepatotoxicityHarun Patel, Rahul Pawara, Kisan Pawara, et al.
Journal of Biomolecular Structure & Dynamics|January 24, 2023
Synthesis, characterization, molecular dynamic simulation, and biological assessment of cinnamates linked to imidazole/benzimidazole as a CYP51 inhibitorAjayrajsinh R Zala, Dhanji P Rajani, Iqrar Ahmad, et al.
Journal of Receptor and Signal Transduction Research|May 1, 2019
Design and synthesis of novel 2,4-disubstituted aminopyrimidines: reversible non-covalent T790M EGFR inhibitorsHarun Patel, Azim Ansari, Rahul Pawara, et al.
Journal of Biochemical and Molecular Toxicology|August 30, 2021
Synthesis, molecular docking, DFT study, and in vitro antimicrobial activity of some 4-(biphenyl-4-yl)-1,4-dihydropyridine and 4-(biphenyl-4-yl)pyridine derivativesAlimamad Malani, Atul Makwana, Jahnvi Monapara, et al.
Combinatorial Chemistry & High Throughput Screening|December 7, 2020
Investigating the Impact of Different Acrylamide (Electrophilic Warhead) on Osimertinib's Pharmacological Spectrum by Molecular Mechanic and Quantum Mechanic ApproachHarun Patel, Iqrar Ahmad, Harsha Jadhav, et al.
Journal of Biomolecular Structure & Dynamics|February 16, 2022
Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitorsYassir Boulaamane, Iqrar Ahmad, Harun Patel, et al.
Journal of Biomolecular Structure & Dynamics|July 26, 2022
Structural modelling and in silico pharmacology of β-carboline alkaloids as potent 5-HT1A receptor antagonists and reuptake inhibitorsYusuf Oloruntoyin Ayipo, Waleed A Alananzeh, Iqrar Ahmad, et al.
Journal of Biomolecular Structure & Dynamics|December 8, 2022
Computational modelling of potential Zn-sensitive non-β-lactam inhibitors of imipenemase-1 (IMP-1)Yusuf Oloruntoyin Ayipo, Iqrar Ahmad, Waleed Alananzeh, et al.
Journal of Medicinal Chemistry|July 29, 2021
Emerging Approaches to Overcome Acquired Drug Resistance Obstacles to Osimertinib in Non-Small-Cell Lung CancerMatin Shaikh, Yashodeep Shinde, Rahul Pawara, et al.
Pageof 11